Omar Ishrak

This profile gathers the share dealings of Omar Ishrak across 3 companies, led by Amgen Inc, Intel Corp and Allurion Technologies, Inc. Between 13 May 2021 and 7 August 2026, the trades on record add up to 26 filings.

On the market, this insider has only ever bought: 3 purchases, €1.3M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 20 share grants and 3 option exercises.

The median purchase comes to €440k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 10 August 2026, reports a share grant in Amgen Inc. The most recent open-market purchase was published on 10 August 2023, 1,165 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.